Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 3910 Reports
🤖 AI Analyzed
Recent
📄 Page 207 of 326

Key Highlights

  • Strong Servicer Compliance confirmed by an independent accounting firm, ensuring...
  • Stable Portfolio Performance with 94.5% of loans by outstanding balance remainin...
  • Successful resolution of two smaller loans in special servicing, recovering a si...
Read Analysis
🤖 AI Generated

Key Highlights

  • Diversified portfolio across multifamily, office, retail, hotel, and industrial ...
  • Trust successfully distributed to senior tranches as scheduled for fiscal year 2...
  • Multifamily and industrial sectors within the portfolio generally show resilienc...
Read Analysis
🤖 AI Generated
BANK 2020-BNK25
10-K March 18, 2026

Key Highlights

  • Operates as an 'issuing entity' (special trust) holding a pool of commercial mor...
  • Realized no significant principal losses during the fiscal year ended December 3...
  • Features a diversified loan portfolio including high-profile assets like the Bel...
Read Analysis
🤖 AI Generated
AEye, Inc.
10-K March 18, 2026

Key Highlights

  • Pioneers advanced lidar technology with its 4Sightâ„¢ intelligent sensing platform...
  • Combines software-controlled lidar with AI-driven perception for superior object...
  • Offers unique advantages like adaptive scanning, long-range detection, and high-...
Read Analysis
🤖 AI Generated
Dogwood Therapeutics, Inc.
10-K March 18, 2026

Key Highlights

  • Strategic pipeline expansion through acquiring Pharmagesic Holdings Inc. and lic...
  • Halneuron, a promising drug candidate for chemotherapy-induced peripheral neurop...
  • Secured approximately $18.5 million in gross proceeds from investor capital offe...
Read Analysis
🤖 AI Generated
BANK 2020-BNK28
10-K March 18, 2026

Key Highlights

  • Smooth transition of servicing responsibilities from Wells Fargo to Trimont LLC.
  • Widespread, independently verified compliance across all administrative function...
  • The CMBS trust operated smoothly throughout 2025, with all service providers con...
Read Analysis
🤖 AI Generated
Energy Vault Holdings, Inc.
10-K March 18, 2026

Key Highlights

  • Robust 65% year-over-year revenue growth to $285 million, driven by new project ...
  • Diversified technology portfolio including gravity-based and battery energy stor...
  • Strong future outlook projecting 30-40% revenue growth for the next fiscal year ...
Read Analysis
🤖 AI Generated
Hyperfine, Inc.
10-K March 18, 2026

Key Highlights

  • Hyperfine, Inc. develops and commercializes innovative, portable MRI systems, wi...
  • The company operates as a Smaller Reporting Company, Non-Accelerated Filer, and ...
  • Strategic focus includes product innovation, market expansion into underserved a...
Read Analysis
🤖 AI Generated
BANK 2021-BNK31
10-K March 18, 2026

Key Highlights

  • BANK 2021-BNK31 is a passive Commercial Mortgage-Backed Securities (CMBS) trust,...
  • The trust's loan portfolio originally totaled $1.2 billion, with an outstanding ...
  • Most loans within the trust performed as expected, with borrowers making timely ...
Read Analysis
🤖 AI Generated
Estrella Immunopharma, Inc.
10-K March 18, 2026

Key Highlights

  • Lead product candidate EB103 showed promising Phase I results with 100% complete...
  • The STARLIGHT-1 clinical trial for EB103 was approved to advance to Phase II by ...
  • The core ARTEMIS® T Cell Receptor Platform aims to create safer, more effective,...
Read Analysis
🤖 AI Generated
dLocal Ltd
20-F March 18, 2026

Key Highlights

  • Revenue grew by 45% year-over-year to $650 million, exceeding previous guidance.
  • Total Payment Volume (TPV) surged by 50% to $15.2 billion, indicating significan...
  • Successfully launched operations in three new high-growth markets: Vietnam, Egyp...
Read Analysis
🤖 AI Generated
PROKIDNEY CORP.
10-K March 18, 2026

Key Highlights

  • Completed enrollment for REACT®'s Phase 3 pivotal trial ahead of schedule in Q3 ...
  • Developing REACT®, a novel, proprietary cell-based therapy aiming to revolutioni...
  • Strong financial position with approximately $210 million in cash and minimal lo...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage